Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study (Q60209721)
Jump to navigation
Jump to search
scientific article published in The Lancet
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study |
scientific article published in The Lancet |
Statements
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study (English)
André J Scheen
Priscilla Hollander
Michael D Jensen
Luc F Van Gaal
RIO-Diabetes Study Group
1 November 2006